1.84% to Target, Cowen & Co. Reiterates Hold Rating for GATX (GATX) Stock, Acasti Pharma Class A (ACST) Shorts Down By 6.98%

July 24, 2017 - By Peter Erickson

Acasti Pharma Class A (NASDAQ:ACST) had a decrease of 6.98% in short interest. ACST’s SI was 144,000 shares in July as released by FINRA. Its down 6.98% from 154,800 shares previously. With 42,800 avg volume, 3 days are for Acasti Pharma Class A (NASDAQ:ACST)’s short sellers to cover ACST’s short positions. The SI to Acasti Pharma Class A’s float is 2.47%. The stock increased 0.78% or $0.01 on July 21, reaching $1.29. About shares traded. Acasti Pharma Inc (NASDAQ:ACST) has declined 3.13% since July 24, 2016 and is downtrending. It has underperformed by 19.83% the S&P500.

Among 6 analysts covering GATX (GATX), 1 have Buy rating, 1 Sell and 4 Hold. Therefore 17% are positive. GATX has $71 highest and $49.0 lowest target. $61.75’s average target is -0.18% below currents $61.86 stock price. GATX had 8 analyst reports since September 30, 2016 according to SRatingsIntel. The firm has “Hold” rating given on Wednesday, June 21 by Longbow. As per Tuesday, December 20, the company rating was initiated by Citigroup. Cowen & Co maintained it with “Hold” rating and $6300 target in Thursday, July 20 report. Citigroup maintained it with “Buy” rating and $71 target in Friday, July 21 report. The firm has “Neutral” rating given on Wednesday, December 14 by Sidoti. CLSA initiated GATX Corporation (NYSE:GATX) on Friday, September 30 with “Underperform” rating. The company was upgraded on Monday, July 17 by Stifel Nicolaus. The company was downgraded on Thursday, January 12 by Stifel Nicolaus.

The stock decreased 1.62% or $1.02 on July 21, reaching $61.86. About shares traded. GATX Corporation (GATX) has risen 36.88% since July 24, 2016 and is uptrending. It has outperformed by 20.18% the S&P500.

GATX Corporation is a global railcar lessor, owning fleets in North America, Europe, and Asia. The company has market cap of $2.39 billion. In addition, the Company operates fleet of the United States-flagged vessels on the Great Lakes and jointly with Rolls-Royce plc, it owns aircraft spare engine lease portfolios in the world. It has a 10.44 P/E ratio. It operates through four business divisions: Rail North America, Rail International, American Steamship Company , and Portfolio Management.

Acasti Pharma Inc is a Canada-based biopharmaceutical company. The company has market cap of $18.83 million. The Firm is focused on the research, development and commercialization of prescription drugs using omega 3 fatty acids derived from krill oil. It currently has negative earnings. OM3s has clinical evidence of safety and efficacy in lowering triglycerides in patients with hypertriglyceridemia (HTG).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com